Key result
Black patients undergoing M-TEER for functional mitral regurgitation had a higher risk of 1-year heart failure readmission compared to White patients.
Why the study?
Mitral transcatheter edge-to-edge repair is recommended for symptomatic functional mitral regurgitation despite medical therapy, but the influence of sex and race on outcomes remains understudied.
Do sex and race influence clinical outcomes following M-TEER for functional mitral regurgitation?
Cohort (n=9,441)
Yes
Do sex and race influence clinical outcomes following M-TEER for functional mitral regurgitation?
Significant racial disparities exist in M-TEER outcomes for FMR, with Black patients experiencing higher 1-year HF readmission rates despite similar or higher baseline GDMT utilization.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Our findings underscore the need for tailored, patient-specific management strategies and highlight the importance of addressing structural inequities in health care to improve outcomes for all patients with FMR.”
May support closer post-M-TEER surveillance in Black patients; leaves open whether targeted interventions can mitigate readmission disparities.
Background: Functional mitral regurgitation (FMR) is associated with poor heart failure (HF) outcomes. Mitral transcatheter edge-to-edge repair (M-TEER) is recommended for symptomatic patients despite medical therapy, though the influence of sex and race on outcomes remains understudied. Methods: We analyzed Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapeutics registry data on patients undergoing M-TEER for FMR (November 2013 to December 2021). Primary outcomes were 30-day and 12-month all-cause and HF hospitalizations and mortality. Cox models adjusted for demographic and clinical variables. However, adjusted 1-year outcomes were like males. Conclusions: Racial and sex disparities in M-TEER outcomes are evident. Black patients present with more advanced disease and experience lower procedural success and higher 12-month HF readmission rates compared to White. Female patients demonstrate lower procedural success but similar long-term adjusted outcomes compared to males. Efforts to address these disparities are essential to improving outcomes for all FMR patients.
No takes yet. Share an insight, caveat, or question.
Park et al. (2026) conducted a cohort in Functional mitral regurgitation (FMR) (n=9,441). Black race vs. White race was evaluated on Heart failure readmission at 12 months (aHR 1.35, 95% CI 1.09-1.67, p=0.006). Black patients undergoing M-TEER for functional mitral regurgitation had a higher risk of 1-year heart failure readmission compared to White patients.
Synapse has enriched 10 related papers. Consider them for comparative context: